Skip to main content
. 2018 Nov 8;21(1):25–32. doi: 10.1007/s12017-018-8517-7

Fig. 5.

Fig. 5

Metformin treatment selectively restores midbrain pAMPK/AMPK in Parkin null mice. Immunoblots show the levels of pAMPK, AMPK, PGC-1α, and PARIS in the ventral midbrain (VM) tissues of 9-month-old Parkin null mice in the absence or presence of metformin treatment (n = 4). Bar graphs show the average densitometric value of pAMPK/AMPK ratio, PGC-1α, and PARIS in untreated and treated Parkin null mice (*p < 0.05 compared to control diet)